Advertisement
Singapore markets open in 8 hours 52 minutes

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,053.27
    -17.28 (-0.34%)
     

  • Dow

    38,360.18
    -143.51 (-0.37%)
     

  • Nasdaq

    15,661.93
    -34.71 (-0.22%)
     

  • Bitcoin USD

    64,857.11
    -1,779.71 (-2.67%)
     

  • CMC Crypto 200

    1,397.60
    -26.50 (-1.86%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Gold

    2,337.90
    -4.20 (-0.18%)
     

  • Crude Oil

    82.84
    -0.52 (-0.62%)
     

  • 10-Yr Bond

    4.6540
    +0.0560 (+1.22%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Company News For Dec 19, 2018

Zacks Equity Research

  • CBS Corp. CBS shares declined 1.3% after the company announced that its former CEO Les Moonves refused to accept $120 million severance package offered by the company’s board of directors

  • Shares of The Boeing Co. BA soared 3.8% after the company raised dividend rate by 20% and increased share repurchase program from $18 billion to $20 billion

  • Darden Restaurants Inc.’s DRI shares surged 5% after the company raised its fiscal 2019 outlook for diluted earnings per share from $5.52-$5.65 to $5.60-$5.70

  • Shares of Tilray Inc. TLRY jumped 16.1% after the company entered into a supply and distribution agreement with Novartis AG NVS for medical marijuana


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CBS Corporation (CBS) : Free Stock Analysis Report
 
Novartis AG (NVS) : Free Stock Analysis Report
 
The Boeing Company (BA) : Free Stock Analysis Report
 
Darden Restaurants, Inc. (DRI) : Free Stock Analysis Report
 
Tilray, Inc. (TLRY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research